Reduced prevalence of latent tuberculosis infection in diabetes patients using metformin and statins

Eur Respir J. 2019 Mar 14;53(3):1801695. doi: 10.1183/13993003.01695-2018. Print 2019 Mar.
No abstract available

Publication types

  • Letter
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibiotics, Antitubercular / therapeutic use
  • Cross-Sectional Studies
  • Diabetes Mellitus, Type 2 / drug therapy*
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use*
  • Hypoglycemic Agents / therapeutic use*
  • Latent Tuberculosis / drug therapy
  • Latent Tuberculosis / epidemiology*
  • Metformin / therapeutic use*
  • Nutrition Surveys
  • United States / epidemiology

Substances

  • Antibiotics, Antitubercular
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Hypoglycemic Agents
  • Metformin